Results 261 to 270 of about 2,931,165 (316)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Bridging Biodiversity and Health: The Global Biodiversity Information Facility's initiative on open data on vectors of human diseases. [PDF]

open access: yesGigaByte
Shimabukuro P   +9 more
europepmc   +1 more source

Data reporting quality and semantic interoperability increase with community-based data elements (CoDEs). Analysis of the open data commons for spinal cord injury (ODC-SCI). [PDF]

open access: yesExp Neurol
Sheoran A   +15 more
europepmc   +1 more source

Preface to the special issue on “Old records for new knowledge”

open access: yesGeoscience Data Journal
Josep Batlló   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy